Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder

NCT05523895 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
237
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ACADIA Pharmaceuticals Inc.